Literature DB >> 24719041

An uncommon cause of acquired osteosclerosis in adults: hepatitis C-associated osteosclerosis.

Narendranath Epperla1, Fergus E McKiernan.   

Abstract

Hepatitis C-associated osteosclerosis (HCAO) is a rare sclerosing bone condition characterized by debilitating, predominantly lower extremity bone pain, accelerated bone turnover, and a generalized increase in histologically normal trabecular and cortical bone tissue. Herein we report the clinical presentation and imaging results of the 19th case of HCAO. Clinicians, particularly those caring for a population at risk for HCV infection, should be aware of this uncommon condition. The etio-pathogenesis of HCAO remains obscure but may bear important lessons in bone biology that could lead to new treatment options for osteoporosis.

Entities:  

Mesh:

Year:  2014        PMID: 24719041     DOI: 10.1007/s00256-014-1882-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  37 in total

1.  Clinical images: Hepatitis C-associated osteosclerosis.

Authors:  Shigeyuki Wakitani; Takako Hattori; Hiroyuki Nakaya; Young Mi Chae; Norikazu Murata; Akira Tanigami
Journal:  Arthritis Rheum       Date:  2003-01

2.  Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-beta signal in osteoblastic cells in the patient with hepatitis C-associated osteosclerosis.

Authors:  H Kaji; J Naito; H Sowa; T Sugimoto; K Chihara
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-11       Impact factor: 2.949

3.  Hyperparathyroidism and increased serum IGF-binding protein-2 levels in hepatitis C-associated osteosclerosis.

Authors:  J L Shaker; B P Moore; M P Whyte
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

4.  A case of hepatitis C-associated osteosclerosis with xanthogranulomatous cholecystitis.

Authors:  Yuji Hataya; Yasato Komatsu; Hideki Chusho; Toshihiko Kirishima; Hiroyuki Shintani; Taisuke Morimoto
Journal:  Intern Med       Date:  2011-08-15       Impact factor: 1.271

5.  Doubling skeletal mass during adult life: the syndrome of diffuse osteosclerosis after intravenous drug abuse.

Authors:  M P Whyte; S L Teitelbaum; W R Reinus
Journal:  J Bone Miner Res       Date:  1996-04       Impact factor: 6.741

6.  Use of site-specific antibodies to characterize the circulating form of big insulin-like growth factor II in patients with hepatitis C-associated osteosclerosis.

Authors:  Sundeep Khosla; F John Ballard; Cheryl A Conover
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

7.  Camurati-Engelmann disease. Effects of corticosteroids.

Authors:  O Heymans; M Gebhart; J Alexiou; Y Sokolow
Journal:  Acta Clin Belg       Date:  1998-06       Impact factor: 1.264

8.  Osteoporosis--an early radiographic sign of endemic fluorosis.

Authors:  Z C Lian; E H Wu
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

9.  Skeletal remodelling and bone related hormones in two adults with increased bone mass.

Authors:  E Manzke; H E Gruber; R W Hiness; D J Baylink
Journal:  Metabolism       Date:  1982-01       Impact factor: 8.694

10.  Camurati-Engelmann disease. Review of radioclinical features.

Authors:  F M Vanhoenacker; K Janssens; W Van Hul; R Gershoni-Baruch; R Brik; A M De Schepper
Journal:  Acta Radiol       Date:  2003-07       Impact factor: 1.701

View more
  1 in total

1.  Hepatitis C-Associated Osteosclerosis: Improvement After Treatment with Sofosbuvir, Daclatasvir, and Ibandronate: Case Report and Literature Review.

Authors:  Maria Carolina de Camargo Vieira; Wagner Rodrigo Brida Gonçalves; Ricardo Ayello Guerra; Fabiana Siroma Callegaro; Marise Lazaretti-Castro; Sergio Setsuo Maeda
Journal:  Calcif Tissue Int       Date:  2021-02-22       Impact factor: 4.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.